BMJ Group Retina Logo
BMJ Group Retina Logo
Find an expert2024-06-07T09:48:34+00:00

Find an expert

Our panel of editors are available for interview

Filters
Expertise

Professor Ronald F. van Vollenhoven

2024-06-27T16:03:26+00:00Expertise : , , |

Editor-in-Chief of Lupus Science & Medicine

Contact

Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.

Professor Caroline Finch AO

2024-06-27T15:43:03+00:00Expertise : |

Editor-in-Chief of Injury Prevention

Contact

Professor Caroline Finch AO is the Deputy Vice-Chancellor (Research), Edith Cowan University. She is one of Australia’s leading injury epidemiologists, particularly known internationally for her public-health-focused injury prevention research. Her influential research has informed the development of injury surveillance and data systems, the implementation and evaluation of preventive measures, and the dissemination of safety advice and guidance. Her research outcomes have directly informed safety policy for Government Departments of Sport and Health, health promotion/injury prevention agencies, and sports bodies worldwide. In 2015, she was awarded the International Distinguished Career Award from the American Public Health Association’s Injury Control and Emergency Health Services Section. In 2018, she became an Officer of the Order of Australia for ‘distinguished service to sports medicine’.

 

Professor John McMillan

2024-06-27T15:46:16+00:00Expertise : , |

Editor-in-Chief of the Journal of Medical Ethics

Contact

Professor John McMillan is a professor for the Bioethics Centre at the University of Otago. He is a member of the Advisory Committee for Assisted Reproductive Technology and the National Screening Advisory Committee, and has published broadly within bioethics.

Karen L Furie, MD

2024-06-27T16:00:56+00:00Expertise : , |

Editor-in-Chief of the Journal of Neurology, Neurosurgery and Psychiatry

Contact

Karen Furie, MD, MPH is Neurologist-in-Chief, Rhode Island Hospital, the Miriam Hospital and Bradley Hospital Samuel I Kennison, MD and Bertha S Kennison Professor of Clinical Neuroscience Chair of Neurology, the Warren Alpert Medical School of Brown University. Clinical and translational stroke research has been a major focus of Karen’s career, and she has enjoyed success in developing collaborative multispecialty initiatives.

Dr Declan Walsh

2024-06-27T15:55:41+00:00Expertise : , , , , , , , |

Editor-in-Chief of BMJ Supportive & Palliative Care

Contact

A pioneer in palliative medicine, Dr Declan Walsh is an internationally renowned physician, researcher, educator and administrator. He developed the first palliative care programme in the United States. In recognition of his achievements, he received the John Mendelsohn Award from MD Anderson Cancer Centre, a lifetime achievement award from the Multinational Association for Supportive Care in Cancer and a Visionary Award from the American Academy of Hospice and Palliative Medicine.

Professor Ganesan Karthikeyan

2024-06-27T16:24:49+00:00Expertise : , , , , , |

Editor-in-Chief Open Heart

Contact

Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.

Go to Top